South Tees Reachese-Prescribing Milestone in EPR Journey, with Alcidion and Better Meds

Alcidion LtdSouth Tees Hospitals NHS Foundation Trust has taken the next step in its modern, modular electronic patient record (EPR) programme with Alcidion, having gone live with electronic prescribing and medication administration (ePMA) system Better Meds.

The trusthas deployed Better Meds to inpatient and outpatient areas, where it is already removing paper forms and manual processes, as well as helping busy healthcare professionals to make safe prescribing decisions.

The ePMA solution fully integrates with Miya Precision, Alcidion's EPR, which is being deployed across the trust to advance digital maturity in ways that respond to clinical priorities and alleviate pressures faced by clinicians. The trust has also simultaneously gone live with electronic discharge notification functionality within the Alcidion Miya Precision system.

Daniel Pugh, a senior informatics pharmacy technician for South Tees Hospitals NHS Foundation Trust, said: "There is a lot of excitement across the trust about the possibilities from this ePMA implementation, and other digitisation taking place in South Tees Hospitals.

"Integrating electronic prescribing into our Alcidion EPR, joins up drug information with patient assessments, allergies, lab results, vital signs and more. This provides a safety barrier that will help prescribers make better informed decisions for patients. It will also save valuable time for clinicians, for example, through easy access to standardised order sets and the ability to prescribe from anywhere.

"Electronic discharge will also become much easier for doctors. Rather than having to manually transcribe medicines, staff just open a discharge letter in Miya Precision, and all the drugs for a patient appear. This reduces the risk of errors and represents animprovement in patient safety."

The trust will now benefit from a better audit trail of every medication dose administered, and staff across wards will gain easier visibility of when medicines are due for patients. "Some medicines require administration within a strict timeframe, for example, drugs related to Parkinson's disease," said Pugh. "We will be able to monitor that and many other scenarios.Trend analysis will allow us to easily identify any potential issues early so we can act swiftly and provide more resources to a ward when needed."

Codified data will also support the trust in financial reporting, so that it can more easily link medicines to specific patientsand reclaim money that can be reinvested into patient care.

The ePMA implementation represents an important step on the trust's journey through stages of the HIMSS Electronic Medical Record Adoption Model. A whole range of additional functionality will complement the go-live as the trust continues to progress its deployment of Miya Precision.

Dr Andrew Adair, chief clinical information officer, at South Tees Hospitals NHS Foundation Trust, said: "E-prescribing is the latest important step on our modular EPR journey, that is allowing us to move at pace towards the highest levels of digital maturity through technology that people want to use.

"Better Meds is highly synergistic with our Alcidion Miya Precision system - and will integrate closely with e-noting, e-observations, patient flow journey boards and more, in ways that reduce the cognitive load for clinicians by making information useful and supporting clinical decisions. Responsibility for prescribing decisions still rests with the clinician, but they will no longer need to manually manage every detail and every process about medicines, conflicts and interactions, guidance and more."

Roko Malkoč, business unit director, Better Meds, added: "South Tees Hospitals NHS Foundation Trust has shown high digital transformation maturity, resulting from the excellent internal alignment driven by an experienced team. We believe that collaboration with Alcidion in the trust will bring direct benefits with real-time access to all healthcare data for caregivers. Both encourage us to follow our vision of medication management without errors."

This deployment represents the first NHS trust to implement an ePMA module as part of an Alcidion EPR programme.

Lynette Ousby, UK managing director for Alcidion, said: "Digitisation in healthcare should be about using technology to respond to clinical and operational priorities in the right order for NHS customers. In this case, e-prescribing will help staff to safely get the right medicines to the right patient, at the right time. South Tees Hospitals is a strong example of a trust that is delivering technology to respond to the needs of its clinicians. Doing that effectively requires flexibility from technology providers and a willingness to work together. It's really rewarding to see the benefits of a modern, modular approach to digitisation working so well in practice."

Kate Quirke, CEO for Alcidion, said: "I'm impressed by the speed at which South Tees Hospitals is progressing its digital journey, and by the enthusiasm for digital transformation at all levels of the organisation. I look forward to seeing the impact of this latest stage of the trust's programme, and to further developments in the near future."

About South Tees Hospitals NHS Foundation Trust

South Tees Hospitals NHS Foundation Trust is the largest hospital trust in the Tees Valley serving the people of Middlesbrough, Redcar and Cleveland, Hambleton and Richmondshire and beyond. The Trust runs The James Cook University Hospital in Middlesbrough and the Friarage Hospital in Northallerton as well as community services in Hambleton and Richmondshire, Middlesbrough and Redcar and Cleveland. The Trust has a workforce of around 9,000 providing a range of specialist regional services to 1.5million people in the Tees Valley and parts of Durham, North Yorkshire and Cumbria, with a particular expertise in heart disease, trauma, neurosciences, renal services, cancer services and spinal injuries.

About Alcidion

Alcidion Group Limited (Alcidion) has a simple purpose, that is, to transform healthcare with proactive, smart, intuitive technology solutions that improve the efficiency and quality of patient care in healthcare organisations, worldwide.

Alcidion offers a complementary set of software products and technical services that create a unique offering in the global healthcare market. Based on the flagship product, Miya Precision, the solutions aggregate meaningful information to centralised dashboards, support interoperability, facilitate communication and task management in clinical and operational settings and deliver Clinical Decision Support at the point of care; all in support of Alcidion's mission to improve patient outcomes.

Since listing on the ASX in 2011, Alcidion has acquired multiple healthcare IT companies and expanded its foothold in the UK, Australia, and New Zealand to now service over 300 hospitals and 60 healthcare organisations, with further geographical expansion planned.

With over 20 years of healthcare experience, Alcidion brings together the very best in technology and market knowledge to deliver solutions that make healthcare better for everyone.

Most Popular Now

Herefordshire and Worcestershire Health …

Herefordshire and Worcestershire Health and Care NHS Trust has successfully implemented Alcidion's Miya Precision platform to streamline bed management workflow across seven community hospitals in Worcestershire. The trust delivers community...

With Huge Patient Dataset, AI Accurately…

Scientists have designed a new artificial intelligence (AI) model that emulates randomized clinical trials at determining the treatment options most effective at preventing stroke in people with heart disease. The model...

A Shortcut for Drug Discovery

For most human proteins, there are no small molecules known to bind them chemically (so called "ligands"). Ligands frequently represent important starting points for drug development but this knowledge gap...

New Horizon Europe Funding Boosts Europe…

The European Commission has announced the launch of new Horizon Europe calls, with a substantial funding pool of over €112 million. These calls are aimed primarily at pioneering projects in...

Cleveland Clinic Study Finds AI can Deve…

Cleveland Clinic researchers developed an artficial intelligence (AI) model that can determine the best combination and timeline to use when prescribing drugs to treat a bacterial infection, based solely on...

New AI-Technology Estimates Brain Age Us…

As people age, their brains do, too. But if a brain ages prematurely, there is potential for age-related diseases such as mild-cognitive impairment, dementia, or Parkinson's disease. If "brain age...

Radboud University Medical Center and Ph…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Radboud University Medical Center have signed a hospital-wide, long-term strategic partnership that delivers the latest patient monitoring...

GPT-4, Google Gemini Fall Short in Breas…

Use of publicly available large language models (LLMs) resulted in changes in breast imaging reports classification that could have a negative effect on patient management, according to a new international...

ChatGPT fails at heart risk assessment

Despite ChatGPT's reported ability to pass medical exams, new research indicates it would be unwise to rely on it for some health assessments, such as whether a patient with chest...

Study Shows ChatGPT Failed when Challeng…

With artificial intelligence (AI) poised to become a fundamental part of clinical research and decision making, many still question the accuracy of ChatGPT, a sophisticated AI language model, to support...

Virtual Reality Shows Promise in Fightin…

A new study published in JMIR Mental Health sheds light on the promising role of virtual reality (VR) in treating major depressive disorder (MDD). Titled "Examining the Efficacy of Extended...

AXREM and Highland Marketing Partner to …

AXREM represents member companies that collectively provide UK hospitals with most of their diagnostic medical imaging technology, and radiotherapy equipment. The association has seen substantial growth in recent years, with membership...